Skip to content
Triangle logo TriangleGet started
← Full study record

NCT03361748 · OUTCOME

AUC 0-9M

Efficacy and Safety Study of bb2121 in Subjects With Relapsed and Refractory Multiple Myeloma · Source last updated 2025-05-23

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
MEAN
Unit
copies*days/ug
Interval / dispersion
Standard Deviation
Time frame
at 9 months post first dose (Approximtately 9 Months)

What was measured

The AUC of the transgene level from the time of dosing to 9 months

Analysis population: PK Evaluable Population for AUC at 9 Months

Groups in this outcome

BB2121

BB2121

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
BB2121122

Reported measurements

Total

Analysis denominator · Participants

GroupSource count
BB2121122
Values in copies*days/ug · Interval/dispersion: Standard Deviation
GroupValueSpreadLowerUpperComment
BB21218634034.709909488.82Not reportedNot reportedNot reported
450x10^6 cells

Analysis denominator · Participants

GroupSource count
BB212160
Values in copies*days/ug · Interval/dispersion: Standard Deviation
GroupValueSpreadLowerUpperComment
BB212110599751.1810833877.42Not reportedNot reportedNot reported
300x10^6 cells

Analysis denominator · Participants

GroupSource count
BB212160
Values in copies*days/ug · Interval/dispersion: Standard Deviation
GroupValueSpreadLowerUpperComment
BB21216604279.358523928.48Not reportedNot reportedNot reported
150x10^6 cells

Analysis denominator · Participants

GroupSource count
BB21212
Values in copies*days/ug · Interval/dispersion: Standard Deviation
GroupValueSpreadLowerUpperComment
BB212110555200.5913555457.13Not reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        spread
        9909488.82
        value
        8634034.70
    denoms
    1. counts
      1. group Id
        OG000
        value
        122
      units
      Participants
    title
    Total
  2. categories
    1. measurements
      1. group Id
        OG000
        spread
        10833877.42
        value
        10599751.18
    denoms
    1. counts
      1. group Id
        OG000
        value
        60
      units
      Participants
    title
    450x10^6 cells
  3. categories
    1. measurements
      1. group Id
        OG000
        spread
        8523928.48
        value
        6604279.35
    denoms
    1. counts
      1. group Id
        OG000
        value
        60
      units
      Participants
    title
    300x10^6 cells
  4. categories
    1. measurements
      1. group Id
        OG000
        spread
        13555457.13
        value
        10555200.59
    denoms
    1. counts
      1. group Id
        OG000
        value
        2
      units
      Participants
    title
    150x10^6 cells
denoms
  1. counts
    1. group Id
      OG000
      value
      122
    units
    Participants
description
The AUC of the transgene level from the time of dosing to 9 months
dispersion Type
Standard Deviation
groups
  1. description
    BB2121
    id
    OG000
    title
    BB2121
param Type
MEAN
population Description
PK Evaluable Population for AUC at 9 Months
reporting Status
POSTED
time Frame
at 9 months post first dose (Approximtately 9 Months)
title
AUC 0-9M
type
SECONDARY
unit Of Measure
copies*days/ug

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice